Investigation Into Fiduciary Breaches Compounds MBAV's SPAC Risks

What happened

MBAV, a SPAC trading near its trust value, is pursuing a de-SPAC with ReserveOne to create a digital asset treasury, but the deal has already slipped past initial close guidance amid liquidity concerns and 'substantial doubt' about going concern. Now, Morris Kandinov LLP has announced an investigation into MBAV, its officers, directors, sponsor MI7, and Cantor Fitzgerald for alleged breaches of fiduciary duty and self-dealing in connection with the ReserveOne combination. The probe centers on ReserveOne being controlled by CC Capital Partners, which also controls the sponsor, raising red flags about insider conflicts and potential harm to public stockholders. This legal scrutiny adds to existing risks like fixed deal costs, high redemption pressures, and a looming Aug 2026 deadline, all documented in recent filings. Consequently, investor confidence is further undermined, threatening the transaction's viability and increasing the likelihood of adverse outcomes.

Implication

Investors must now factor in heightened fiduciary risks, as the investigation could prolong SEC review and shareholder approval processes, pushing the deal closer to its liquidation deadline. Redemption rates are likely to spike as holders seek to avoid legal entanglement and dilution from fixed costs like the $13.4M deferred underwriting discount. The sponsor's alignment is under scrutiny, potentially leading to weaker deal terms or even abandonment, exacerbating MBAV's already precarious financial position. This development shifts the risk-reward balance negatively, reducing the probability of a successful close and making the 'WAIT' rating more imperative. Overall, the news underscores the need for investors to monitor legal filings closely and consider reducing exposure until greater transparency emerges.

Thesis delta

The investment thesis, previously centered on waiting for S-4 progress and a vote date, now incorporates significant legal and fiduciary risks from the investigation. This shift increases timeline uncertainty and erodes investor confidence, making a successful de-SPAC less probable and urging a more cautious approach. Investors should prioritize risk mitigation by watching for updates on the investigation and any impact on deal mechanics.